Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia.
about
Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infectionSafety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaDecay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis casesEnzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection.Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The GambiaReversion of the ELISPOT test after treatment in Gambian tuberculosis cases.Health seeking behaviour, health system experience and tuberculosis case finding in Gambians with cough.Risk factors for pulmonary tuberculosis: a clinic-based case control study in The GambiaUsing ELISPOT to expose false positive skin test conversion in tuberculosis contactsComparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia.Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contactsSensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression.Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin testImproving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants.School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South AfricaImmunogenicity of antigens from the TbD1 region present in M. africanum and missing from "modern" M. tuberculosis: a cross- sectional studyUse of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contactsSafety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and ArgentinaImmune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda.ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the GambiaRisk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West AfricansDifferences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an updateMCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphismsT-cell assay conversions and reversions among household contacts of tuberculosis patients in rural IndiaComparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population.New approaches in the diagnosis and treatment of latent tuberculosis infectionNew tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.Recombinant ESAT-6-CFP10 Fusion Protein Induction of Th1/Th2 Cytokines and FoxP3 Expressing Treg Cells in Pulmonary TBLatent TB infection diagnosis in population exposed to TB subjects in close and poor ventilated high TB endemic zone in India.Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.What has Karonga taught us? Tuberculosis studied over three decades.Risk for tuberculosis among children.Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.
P2860
Q21296755-B1FC2220-A03F-4EFA-B26F-F339D99C7D10Q28473318-0C07FAD5-A529-4CBA-9D33-69C1474EEB49Q28475371-9C04CCD8-780F-4E0A-9C7D-E4EE36D361F0Q30489177-C088C057-4631-4706-AEE8-313DD4553F17Q30828531-9F7657C1-2300-402A-9DED-AE5750CA11ADQ33238061-C23E8563-85F4-464C-8D7B-443E545A6DE0Q33245737-47984B34-23E1-42D8-9DB6-98E8DB70D81EQ33247215-68AFA774-CEF0-4DCA-B799-E99861F3224DQ33271020-0441D7AE-6300-4DA7-8509-09CE0F4B2DA5Q33303921-32D7AE07-8124-4A79-83EF-D23CA8FD927FQ33312938-970F4CAF-0056-4B08-9DDB-CBDF2FB6C01AQ33314906-5FF1B258-BA6C-4F7A-B576-A11020C50787Q33334644-8234F6DD-EFCA-4DD0-A439-2EC3493A29AAQ33358065-45753036-9C2A-45C0-830B-34B0FDE2E273Q33358114-0E8F44D9-3AE4-489A-8CDD-A361CB0DCBE4Q33377580-CA68B51A-3EDB-4243-A3C6-FBFAD699683BQ33516016-741BB0A0-61E5-451B-9A6A-B92D84074AC3Q33525188-2817CD89-CF80-4E53-9062-2F8F5108FD26Q33790058-2874E0ED-BE23-411A-B4F8-5BD1553EFD5DQ33807147-4B1B2578-AF9C-437F-8008-E7C3309C3CCCQ33826089-5BCCE6EF-5349-4AA9-AA3C-3D804D2EF217Q33847573-B3A4B97D-4E47-4A69-A3B3-9C0EB3D5C4B3Q33859249-6D65111B-0895-4BAC-B2F2-BEFA632BBB4BQ33869437-69E73A3B-AB02-4BED-87CD-A5DB1A3BACE3Q33986153-A9FD3F8A-522C-4B82-986F-34E495ECF937Q34070702-000A158E-640E-4891-A26F-A3BAA894CC5DQ34182471-D8AD1A85-5964-4904-9B2A-725DA0795B4AQ34185340-309D0E90-C1D3-44D8-8D56-0CF3159D3EF0Q34325903-F83CE094-25CA-4630-9564-76B5C6068560Q34419185-78B731AD-E520-43EF-A485-BEDE2B6085CDQ34527311-D1B22A59-6E40-4753-8F80-2FB9EF744B63Q34719407-CCBF239A-0ED8-49DC-8A84-386206B65F3BQ34790516-8861E9A3-1BF1-40E0-AAB8-090EA24775BDQ34797776-9DF58BAF-99E2-428A-80D8-C809368D933EQ35116232-DBFA5035-D0D0-4DCC-A248-BFED8D086016Q35336540-AD9DCA31-DDD0-4D8F-B26F-80883106E40CQ35575115-D5DA6271-20B6-40F0-9C16-CCA63CFFD783Q35737870-BF1EA3A5-DF9E-43DE-9726-5358AFDF0123Q35805718-9A4FB6FB-73C9-4CB3-A36E-B90E48B46393Q35840672-7B3285B8-BBEB-439D-BB2D-BAEA991C3445
P2860
Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Large-scale evaluation of enzy ...... ent of exposure in The Gambia.
@en
Large-scale evaluation of enzy ...... ent of exposure in The Gambia.
@nl
type
label
Large-scale evaluation of enzy ...... ent of exposure in The Gambia.
@en
Large-scale evaluation of enzy ...... ent of exposure in The Gambia.
@nl
prefLabel
Large-scale evaluation of enzy ...... ent of exposure in The Gambia.
@en
Large-scale evaluation of enzy ...... ent of exposure in The Gambia.
@nl
P2093
P50
P356
P1476
Large-scale evaluation of enzy ...... ent of exposure in The Gambia.
@en
P2093
Abdulrahman S Hammond
Annette Fox
David J Jeffries
Dolly Jackson-Sillah
Jacob K Otu
Katherine Fielding
Keith P W J McAdam
Moses D Lugos
Philip C Hill
Roger H Brookes
P304
P356
10.1086/382362
P407
P577
2004-03-16T00:00:00Z